Dajao, Baby Boy .

HRN: 21-99-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/08/2022
10/15/2022
IV
14mg
Q24
PSNB Sec To Thickly MSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: